All In Biotech

Free tool

FAERS Monitor: Fluorescite

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021980 or its brand name (Fluorescite, Fluorescein Sodium). Reports on generic versions are filed under their own applications.

Reports

564

Serious

539

96% of reports

Hospitalization

154

Death reported

34

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea72
  • anaphylactic shock56
  • pruritus54
  • dyspnoea52
  • dizziness50
  • vomiting49
  • rash47
  • loss of consciousness45
  • visual acuity reduced37
  • chest discomfort31
  • urticaria31
  • asthenia25
  • blood pressure decreased23
  • drug hypersensitivity23
  • syncope22

Reports by year received

View as table
YearReports
20047
200510
20067
20077
200814
200976
201023
201112
201215
201311
201426
201524
201630
201720
201822
201935
202056
202122
202228
202331
202439
202534
202615

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,595 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaphylactic shockSignal5681.263.34,352
visual acuity reducedSignal3741.630.51,426
loss of consciousnessSignal4513.19.9494
blood pressure decreasedSignal2312.98.7242
chest discomfortSignal3111.38.0282
syncopeSignal228.25.4133
urticariaSignal316.94.9152
pruritusSignal545.24.1184
drug hypersensitivitySignal234.43.058
rashSignal474.03.1106
vomitingSignal493.93.0105
dizzinessSignal503.72.9100
dyspnoeaSignal523.42.689
nauseaSignal723.42.7124
astheniaSignal252.51.721

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.